Adolescents with overweight or obesity and asthma had a lower risk of asthma exacerbations after starting a GLP-1 receptor ...

Marketed as Exdensur, the ultra-long-acting biologic is the first of its kind, requiring only two injections per year to ...

Children conceived through assisted reproductive technology (ART) were modestly more likely to develop asthma, allergic ...

An asthma treatment that only requires patients to have two jabs a year to prevent life-threatening attacks will be available ...

The study is part of a growing body of research examining the benefits of climate change solutions on human health.

The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

Small New Year's resolutions could make a big difference in the severity of people allergies and asthma, according to an ...

Coughing and wheezing can leave anyone wondering whether it is asthma or bronchitis at play. Both of these respiratory issues ...

Regarding who can use these inhalers, NHS guidelines state: "Most adults can use beclometasone inhalers for asthma or COPD.

With a fresh endorsement from the FDA, the last of five major drug approvals has fallen into place for GSK in 2025. | Tuesday ...

This year’s top asthma and respiratory disorder story focused on the pushback from multiple advocacy groups following ...

On average, 10.6% of Louisiana adults reported ever being told by a health professional that they have asthma. These parishes ...